Sanyin Bio

圣因生物

Sanyin Bio

Biotech/Healthcare

Founded in early 2021, Shengyin Biotech is a biopharmaceutical company focused on developing novel small nucleic acid drugs based on RNA interference (RNAi) technology, with R&D centers in China and the United States. Its founding team comprises seasoned experts in nucleic acid drugs, with…

Latest round: Series B (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-12-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.